Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Bioventus Inc before investing.

In this article, we go over a few key elements for understanding Bioventus Inc’s stock price such as:

• Bioventus Inc’s current stock price and volume
• Why Bioventus Inc’s stock price changed recently
• Upgrades and downgrades for BVS from analysts
• BVS’s stock price momentum as measured by its relative strength

About Bioventus Inc (BVS)

Before we jump into Bioventus Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.

Want to learn more about Bioventus Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Bioventus Inc.

Bioventus Inc’s Stock Price as of Market Close

As of September 26, 2024, 4:00 PM, CST, Bioventus Inc’s stock price was $11.05.

Bioventus Inc is down 4.91% from its previous closing price of $11.62.

During the last market session, Bioventus Inc’s stock traded between $11.42 and $11.79. Currently, there are 64.06 million shares of Bioventus Inc stock available for purchase.

Unfortunately, Bioventus Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Bioventus Inc Stock Price History

Bioventus Inc’s (BVS) price is currently up 9.95% so far this month.

During the month of September, Bioventus Inc’s stock price has reached a high of $12.03 and a low of $9.12.

Over the last year, Bioventus Inc has hit prices as high as $12.03 and as low as $2.85. Year to date, Bioventus Inc’s stock is up 323.37%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Bioventus Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 25, 2024, there was 1 analyst who downgraded Bioventus Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Bioventus Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Bioventus Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Bioventus Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Bioventus Inc (BVS) by visiting AAII Stock Evaluator.

Relative Price Strength of Bioventus Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 25, 2024, Bioventus Inc has a weighted four-quarter relative price strength of 49.08%, which translates to a Momentum Score of 98 and is considered to be Very Strong.

Want to learn more about how Bioventus Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Bioventus Inc Stock Price: Bottom Line

As of September 26, 2024, Bioventus Inc’s stock price is $11.05, which is down 4.91% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Bioventus Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.